Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2003
08/14/2003US20030152614 Enhanced drug delivery in transdermal systems
08/14/2003US20030152613 Steroid on carrier containing pressure sensitive adhesive
08/14/2003US20030152612 Multilayer flexible patch; transdermal skin therapy
08/14/2003US20030152611 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
08/14/2003US20030152602 Topical applying; tissue penetration; bioavailability
08/14/2003US20030152595 Storage stability
08/14/2003US20030152585 Herbal formulation
08/14/2003US20030152531 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same
08/14/2003US20030152523 Prepared by spray-drying hydrophobic active agent (e.g. declomethasone dipropionate) with a small quantity of pharmaceutically acceptable hydrophilic polymer (e.g. polyvinyl alcohol); asthma
08/14/2003US20030152522 System for delivering antiadhesion composition comprising canister containing composition, valve adapted to permit flow of antiadhesion composition therethrough, pressure source; surgery
08/14/2003US20030152521 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
08/14/2003US20030152517 Method and composition for hyperthermally treating cells
08/14/2003US20030152500 Rotor-stator apparatus and process for the formation of particles
08/14/2003US20030150832 Delivery device
08/14/2003US20030150447 Metered dose inhaler
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2482559A1 Processes for preparing crystalline and amorphous mupirocin calcium
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475211A1 Lyophilised preparation comprising immunocytokines
08/14/2003CA2475187A1 Therapeutic polyesters and polyamides
08/14/2003CA2475071A1 Stabilization of protein preparations
08/14/2003CA2474922A1 Microinfusion device
08/14/2003CA2474921A1 Pharmaceutical tablet
08/14/2003CA2474919A1 Formulation comprising bioactive agents and method of using same
08/14/2003CA2474398A1 New immunoeffector compounds
08/14/2003CA2474190A1 Pharmaceutical dosage form for mucosal delivery
08/14/2003CA2473720A1 Method for producing water-dispersible dry powders from poorly soluble compounds
08/14/2003CA2473143A1 Compositions containing oat straw and willowherb extract
08/14/2003CA2472249A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
08/14/2003CA2471631A1 Primary rat hepatocyte toxicity modeling
08/14/2003CA2469748A1 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003CA2466251A1 Therapeutic use of aziridino compounds
08/14/2003CA2455881A1 A stable pharmaceutical formulation comprising torsemide modification ii
08/13/2003EP1335018A1 Sericin-containing material, process for producing the same and method of using the same
08/13/2003EP1334765A1 Process for producing liposome and apparatus therefor
08/13/2003EP1334732A1 Pharmaceutical preparation containing copolyvidone
08/13/2003EP1334724A1 Compositions for external preparations
08/13/2003EP1334723A1 Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2- 2- 4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient
08/13/2003EP1334722A1 Granular drug preparations containing branched amino acids and process for producing the same
08/13/2003EP1334721A1 Nateglinide-containing hydrophilic drug preparations
08/13/2003EP1334718A1 Drug composition comprising dipeptydyl aldehyde derivative
08/13/2003EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration
08/13/2003EP1334716A1 Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
08/13/2003EP1334201A2 Dna expression vectors
08/13/2003EP1334091A2 Thioflavin derivatives and their use in diagnosis and therapy of alzheimer's disease
08/13/2003EP1333880A1 Transdermal drug delivery devices having coated microprotrusions
08/13/2003EP1333865A1 Inorganic low density radionuclide coated particles
08/13/2003EP1333858A1 Vaccines with enhanced immune response and methods for their preparation
08/13/2003EP1333851A1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
08/13/2003EP1333846A1 Preparation and xenotransplantation or porcine islets
08/13/2003EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids
08/13/2003EP1333825A1 Method for enhanced delivery of oxybutynin and compositions thereof
08/13/2003EP1333823A1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
08/13/2003EP1333819A2 Inhalative solution formulation containing a tiotropium salt
08/13/2003EP1333818A2 Titratable dosage transdermal delivery system
08/13/2003EP1333817A2 Film for active ingredients dermal and transdermal administration
08/13/2003EP1333816A2 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
08/13/2003EP1333815A1 Process for producing microparticles
08/13/2003EP1333814A1 Parenterally administrable microparticles
08/13/2003EP1333813A2 Process for the preparation of an oral delivery device
08/13/2003EP1333812A1 Microgranules based on active principle and method for making same
08/13/2003EP1333811A1 Liposomal formulation of mitoxantrone
08/13/2003EP1333810A2 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333807A2 Extended release erythromycin derivatives
08/13/2003EP1333806A2 Bdellosomes
08/13/2003EP1333802A2 Mixture for treating skin
08/13/2003EP1256340B1 Improved transdermal therapeutic system for the treatment of Parkinson's disease
08/13/2003EP1220656B1 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase
08/13/2003EP1163008B1 Use of trehalose for stabilising a liquid vaccine
08/13/2003EP1148793B1 Method of preparing microparticles of phytosterols or phytostanols
08/13/2003EP1135036A4 Smoking products containing antioxidants
08/13/2003EP1082089B1 Devices with coatings containing chlorhexidine gluconate, compositions and methods
08/13/2003EP1023016B1 Solid state fluid delivery system
08/13/2003EP0914096B1 Microparticles and their use in wound therapy
08/13/2003EP0840570B1 Apparatus and method for making gas-filled vesicles of optimal size
08/13/2003EP0812213B1 Gel form of a vaccine
08/13/2003EP0784470B1 Liposome-formulations for treatment of viral diseases
08/13/2003EP0772462B1 Alginate fibres, method of preparation and use
08/13/2003EP0762871B1 Stabilisation of photosensitive materials
08/13/2003EP0743842B1 Drug-containing adhesive composite transdermal delivery device
08/13/2003EP0712422B2 Method for preparing a gelled aqueous composition and use thereof
08/13/2003CN1436077A Stabilized pharmaceutical compositions contg. calcium channel blockers
08/13/2003CN1436073A Management of snoring by oral administration of dimethyl sulfone
08/13/2003CN1436072A Composition, kits, and methods for promoting defined health benefits
08/13/2003CN1436071A Plaster
08/13/2003CN1435261A Thermosetting medical carrier composition with mucosa adsorption
08/13/2003CN1435258A Recombinant human granulocyte-macrophage colony stimulating factor gel
08/13/2003CN1435256A Oral collagen Ôàí film preparation
08/13/2003CN1435251A ÔÇ£SanhuangÔÇØ drip pill and preparing method thereof
08/13/2003CN1435250A Method for preparing oralÔÇ£mailuolingÔÇØ solid preparation for injection
08/13/2003CN1435241A Single-ingredient Chinese medicine pill and tablet
08/13/2003CN1435228A Use of American ginseng spray in treating recurring mouth ulcer
08/13/2003CN1435225A Medical ointment ÔÇ£JiaoxuanxiaoÔÇØ for treating athlete's foot
08/13/2003CN1435210A Skin Chinese medicine disinfectant liquid and use thereof for suppressing prospermia
08/13/2003CN1435190A Meridians-activating pain-alleviating plaster for treating pains of neck, shoulder, waist and leg
08/13/2003CN1435189A Ointment for treating fracture and injury
1 ... 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 ... 2991